Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: A randomized control trial

Keyphrases

• Randomized Controlled Trial 100%
• Vasopressors 100%
• Septic Shock 100%
• Levocarnitine 100%
• Placebo 50%
• Serious Adverse Events 50%
• Quick Sequential Organ Failure Assessment (qSOFA) 50%
• Potential Gains 16%
• Patient-centered 16%
• Sepsis 16%
• Safety Outcomes 16%
• Metabolic Dysfunction 16%
• Improved Survival 16%
• Long-term Survival 16%
• Normal Saline 16%
• Metabolic Disturbances 16%
• Efficacy Data 16%
• Consensus Definition 16%
• Carnitine Deficiency 16%
• Primary Safety 16%
• Carnitine 16%
• Efficacy Outcomes 16%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Infusion 100%
• Hypertensive Factor 100%
• Septic Shock 100%
• Carnitine 100%
• Adverse Event 42%
• SOFA Score 42%
• Placebo 42%
• Water-Electrolyte Imbalance 14%
• Arm 14%
• Sepsis 14%
• Long Term Survival 14%
• Carnitine Deficiency 14%
• Table Salt 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Hypertensive Factor 100%
• Carnitine 100%
• Septic Shock 100%
• Placebo 42%
• Adverse Event 42%
• Organ Dysfunction Score 42%
• Long Term Survival 14%
• Carnitine Deficiency 14%
• Sepsis 14%
• Table Salt 14%
• Metabolic Disorder 14%